Shenzhen Salubris Pharmaceuticals Co., Ltd.
SZSE:002294.SZ
29.64 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||||||||
| Net Income
| 580.066 | 634.218 | 528.322 | 50.135 | 681.841 | 1,454.581 | 1,436.88 | 1,390.039 | 1,269.674 | 1,043.384 | 833.26 | 635.552 | 405.448 | 355.51 | 215.679 | 116.942 | 73.138 | 34.239 |
| Depreciation & Amortization
| 375.438 | 320.158 | 304.268 | 246.025 | 229.362 | 167.361 | 125.974 | 112.732 | 75.673 | 63.342 | 53.847 | 41.497 | 31.734 | 19.907 | 13.252 | 8.053 | 6.681 | 4.81 |
| Deferred Income Tax
| -13.126 | 20.921 | -3.571 | -37.135 | -7.766 | -1.121 | -6.127 | 8.878 | 13.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 25.914 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -163.99 | -140.914 | 297.411 | 740.024 | 367.617 | -272.88 | -82.134 | -81.874 | -293.558 | -111.106 | -230.232 | -169.772 | -183.087 | -197.009 | -101.606 | -49.784 | -27.89 | -28.073 |
| Accounts Receivables
| 3.962 | -89.416 | 69.975 | 613.445 | 356.351 | -61.1 | 16.885 | -32.996 | -158.453 | -165.507 | -323.611 | -189.13 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 51.233 | -114.11 | -46.531 | 111.424 | 67.55 | -86.932 | -154.404 | 17.102 | -188.743 | 10.227 | 65.257 | -56.672 | 55.541 | -74.917 | -51.295 | -25.09 | -28.984 | -5.749 |
| Accounts Payables
| -219.185 | 41.691 | 277.539 | 52.29 | -48.518 | -123.726 | 61.512 | -74.858 | 40.637 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0 | 20.921 | -3.571 | -37.135 | -7.766 | -185.948 | 72.27 | -98.975 | -104.815 | -121.333 | -295.489 | -113.1 | -238.627 | -122.092 | -50.311 | -24.694 | 1.094 | -22.324 |
| Other Non Cash Items
| 1,006.269 | 135.681 | 54.977 | 338.145 | 227.825 | -8.399 | -22.998 | 13.915 | 4.24 | -13.371 | 11.646 | 13.937 | 18.223 | 8.242 | 6.957 | 2.682 | 0.825 | 1.029 |
| Operating Cash Flow
| 869.792 | 970.805 | 1,184.979 | 1,374.329 | 1,506.645 | 1,340.664 | 1,457.722 | 1,434.812 | 1,056.029 | 982.249 | 668.522 | 521.214 | 272.319 | 186.649 | 134.282 | 77.893 | 52.754 | 12.005 |
| Investing Activities: | ||||||||||||||||||
| Investments In Property Plant And Equipment
| -670.999 | -598.96 | -482.501 | -642.465 | -457.186 | -332.87 | -331.668 | -245.057 | -235.569 | -200.654 | -427.203 | -286.749 | -252.6 | -223.478 | -135.677 | -61.479 | -13.705 | -9.705 |
| Acquisitions Net
| 0.615 | -82.842 | 1.593 | 643.359 | 457.331 | -213.896 | 332.004 | 245.813 | -414.238 | -202.719 | 0 | 0 | 252.646 | 223.478 | 0 | 61.479 | 0 | 9.705 |
| Purchases Of Investments
| -2,140.98 | -1,371.093 | -498.079 | -858.293 | -2,389.072 | -2,795.926 | -3,197.906 | -312.841 | -752.5 | -746 | -200 | -1.5 | -170 | -50 | 0 | -35 | 0 | -10 |
| Sales Maturities Of Investments
| 1,410.225 | 696.159 | 609.339 | 650.424 | 2,633.806 | 2,408.938 | 2,325.913 | 27.138 | 956.421 | 716.531 | 0 | 0 | 171.007 | 50.374 | 0 | 35.066 | 1.9 | 8.1 |
| Other Investing Activites
| 0 | 83.428 | 0 | -642.465 | -457.186 | 0.73 | -331.668 | -245.057 | 0.008 | 0.024 | 0.011 | 0.017 | -252.6 | -223.478 | 3 | -61.479 | -13.705 | -9.705 |
| Investing Cash Flow
| -1,401.139 | -1,273.308 | -369.648 | -849.44 | -212.306 | -933.024 | -1,203.326 | -530.003 | -445.878 | -432.819 | -627.192 | -288.232 | -251.546 | -223.104 | -132.677 | -61.414 | -11.805 | -11.605 |
| Financing Activities: | ||||||||||||||||||
| Debt Repayment
| -134.895 | -183.6 | -639.518 | -277.716 | -37.704 | -74.503 | -15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -139.2 | -31.75 | -16.13 | -23.74 |
| Common Stock Issued
| 0 | 300.5 | 392.351 | 284.944 | 63.133 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | -274.305 | -327.859 | -284.944 | -63.133 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -545.68 | -437.564 | -1.6 | -515.928 | -836.813 | -843.452 | -1,161.021 | -206.395 | -458.845 | -392.256 | -305.088 | -163.44 | -136.2 | -113.5 | -2.774 | -2.328 | -30.718 | -0.565 |
| Other Financing Activities
| -24.961 | 197.102 | 2,139.798 | 45.673 | 60.867 | 320.723 | 42.662 | 6.35 | 0.335 | -0.035 | 0 | 0 | 4.492 | -3.597 | 1,243.074 | 44.044 | 25.078 | 23.352 |
| Financing Cash Flow
| -705.535 | -401.5 | 1,548.328 | -766.858 | -829.591 | -597.232 | -1,133.36 | -200.045 | -458.51 | -392.291 | -305.088 | -163.44 | -131.708 | -117.097 | 1,101.099 | 9.966 | -21.77 | -0.953 |
| Other Information: | ||||||||||||||||||
| Effect Of Forex Changes On Cash
| 4.067 | 32.961 | -6.775 | -4.838 | 2.083 | 5.781 | -5.889 | 3.58 | 2.702 | 0.011 | -0.775 | -0.248 | -0.737 | -0.577 | -0 | 0 | 0 | -0 |
| Net Change In Cash
| -1,348.492 | -671.042 | 2,356.884 | -246.808 | 466.831 | -183.811 | -884.852 | 708.344 | 154.343 | 157.15 | -264.533 | 69.294 | -111.673 | -154.129 | 1,102.704 | 26.445 | 19.178 | -0.554 |
| Cash At End Of Period
| 1,321.975 | 2,550.976 | 3,222.018 | 865.135 | 1,111.942 | 645.111 | 828.922 | 1,713.774 | 1,005.43 | 851.087 | 693.937 | 958.47 | 889.176 | 1,000.85 | 1,154.979 | 52.274 | 25.829 | 6.651 |